Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients.
<h4>Objectives</h4>Mac-2-binding protein glycosylation isomer (M2BPGi) is a novel plasma biomarker for liver fibrosis, but less is known about its role in portal hypertension. We aimed to evaluate the association between M2BPGi and hepatic venous pressure gradient (HVPG) and to investiga...
Guardado en:
Autores principales: | Pei-Shan Wu, Yun-Cheng Hsieh, Kuei-Chuan Lee, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c29ffe58320407f85d31af9c5377753 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
por: Gioia S, et al.
Publicado: (2021) -
The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.
por: Christian Jansen, et al.
Publicado: (2014) -
Laparoscopic splenectomy via the spleen bed in combination with selective esophagogastric devascularization for patients with cirrhotic portal hypertension: a single-institution experience
por: Xiaopei Hao, et al.
Publicado: (2019) -
Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.
por: Romain Coriat, et al.
Publicado: (2011) -
Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients
por: Magda Ibrahim, et al.
Publicado: (2020)